Unique ID issued by UMIN | UMIN000001401 |
---|---|
Receipt number | R000001703 |
Scientific Title | Phase II study of S-1 and CDDP as neoadjuvant chemotherapy for patients with lymph node metastasis from resectable gastric cancer |
Date of disclosure of the study information | 2012/10/01 |
Last modified on | 2014/07/16 12:21:48 |
Phase II study of S-1 and CDDP as neoadjuvant chemotherapy for patients with lymph node metastasis from resectable gastric cancer
CDDP+S-1 as neoadjuvant chemotherapy for resecatbele lymph node metastatic gastric cancer
Phase II study of S-1 and CDDP as neoadjuvant chemotherapy for patients with lymph node metastasis from resectable gastric cancer
CDDP+S-1 as neoadjuvant chemotherapy for resecatbele lymph node metastatic gastric cancer
Japan |
Resecatbele lymph node metastatic gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the safety and efficacy of CDDP and S-1 as neoadjuvant chemotherapy for patients with lymph node metastasis from gastric cancer.
Efficacy
Exploratory
Pragmatic
Phase II
Complete resection rate
Compliance of treatment tolerance
Response rate
Relapse Free Survival (3years)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
CDDP 60 mg/m2 one-hour days 8, S-1 80 mg/m2 PO days 1-21, every 35 days for 2 cycles followed by gastrectomy with D2 lymph node dissection
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Histologically or cytologically confirmed adenocarcinoma of the stomach,
curative resection possible by total body computed tomography (CT) scan.
Age 20-80 years old,
No prior therapy including surgery, radiotherapy or chemotherapy for current disease,
patients who can take medication orally,
ECOG performance status 0-1,
Adequate cardiac, hepatic, renal, respiratory, and bone marrow functions, Written informed consent.
A history of other malignancies within the last 5 years except for adequately treated non-melanoma skin cancer or carcinoma in situ of the cervix,
patients contraindicated to S-1,
A history of severe drug hypersensitivity,
Uncontrolled medical conditions , Documented or suspected infection, Patients requiring treatment with corticosteroids except for pre-medication,
Hepatitis B or C,
patients with diarrhea,
Pregnant or lactating women and women of child bearing potential not using contraception,
Severe psychiatric disorders,
Severe edema,
Grade 2 or grater peripheral neuropathy,
HIV positive,
patients judged by the investigator as unfit to be enrolled in the study.
50
1st name | |
Middle name | |
Last name | Mitsugu Kochi |
Nihon University School of Medicine
Department of Digestive Surgery
30-1 Ohyaguchi Kamimachi, Itabashi-ku, Tokyo
03-3972-8111
kochi.mitsugu@nihon-u.ac.jp
1st name | |
Middle name | |
Last name | Mitsugu Kochi |
Nihon University School of Medicine
Department of Digestive Surgery
30-1 Ohyaguchi Kamimachi, Itabashi-ku, Tokyo
03-3972-8111
kochi.mitsugu@nihon-u.ac.jp
Nihon University School of Medicine
Nihon University School of Medicine
Self funding
NO
日本大学医学部附属板橋病院(東京都)
Nihon University School of Medicine Itabashi Hospital(Tokyo)
2012 | Year | 10 | Month | 01 | Day |
Published
Completed
2002 | Year | 04 | Month | 01 | Day |
2002 | Year | 04 | Month | 01 | Day |
2013 | Year | 10 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2008 | Year | 09 | Month | 29 | Day |
2014 | Year | 07 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001703